tiprankstipranks
Scinai Immunotherapeutics Strives for Nasdaq Compliance
PremiumCompany AnnouncementsScinai Immunotherapeutics Strives for Nasdaq Compliance
13d ago
Scinai Immunotherapeutics receives updated LOI from EIB
PremiumThe Fly
Scinai Immunotherapeutics receives updated LOI from EIB
13d ago
Scinai Immunotherapeutics reports Q1 EPS ($0.001c) vs ($0.003) last year
PremiumThe Fly
Scinai Immunotherapeutics reports Q1 EPS ($0.001c) vs ($0.003) last year
19d ago
Scinai Immunotherapeutics regains Nasdaq compliance
PremiumThe FlyScinai Immunotherapeutics regains Nasdaq compliance
1M ago
Scinai Immunotherapeutics Faces Nasdaq Compliance Issues
PremiumCompany Announcements
Scinai Immunotherapeutics Faces Nasdaq Compliance Issues
2M ago
Scinai Immunotherapeutics receives Nasdaq staff determination letter
PremiumThe Fly
Scinai Immunotherapeutics receives Nasdaq staff determination letter
2M ago
Scinai Immunotherapeutics Advances NanoAb Pipeline
PremiumCompany AnnouncementsScinai Immunotherapeutics Advances NanoAb Pipeline
3M ago
Scinai Targets IL-17 in Psoriasis Drug Development
PremiumCompany Announcements
Scinai Targets IL-17 in Psoriasis Drug Development
3M ago
Scinai Immunotherapeutics’ CDMO unit selected by Ayana Pharma
PremiumThe Fly
Scinai Immunotherapeutics’ CDMO unit selected by Ayana Pharma
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100